71 related articles for article (PubMed ID: 2894670)
1. [Osteocalcin: an index of development of acromegaly?].
Oberlin F; Guillemant J; Guillemant S; Loison S; Turpin G
Presse Med; 1988 Feb; 17(4):166. PubMed ID: 2894670
[No Abstract] [Full Text] [Related]
2. Dynamics of injected somatostatin in blood of patients with hepatic failure and acromegaly.
Kastin AJ; Arimura A; Gonzalez-Barcena D; Fishback J; Schally AV; Coy DH
Peptides; 1980; 1(3):257-9. PubMed ID: 6112735
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of therapy-resistant acromegaly using Sandostatin].
von Werder K; Mehltretter G; Müller OA
Z Gastroenterol; 1990 Sep; 28 Suppl 2():29-31. PubMed ID: 1980775
[No Abstract] [Full Text] [Related]
4. Associations between body composition, circulating interleukin-1 receptor antagonist, osteocalcin, and insulin metabolism in active acromegaly.
Ueland T; Fougner SL; Godang K; Lekva T; Schurgers LJ; Scholz H; Halvorsen B; Schreiner T; Aukrust P; Bollerslev J
J Clin Endocrinol Metab; 2010 Jan; 95(1):361-8. PubMed ID: 19880791
[TBL] [Abstract][Full Text] [Related]
5. The response of serum growth hormone levels to the long-acting somatostatin analog SMS 201-995 in acromegaly.
Comi RJ; Gorden P
J Clin Endocrinol Metab; 1987 Jan; 64(1):37-42. PubMed ID: 2878009
[TBL] [Abstract][Full Text] [Related]
6. Effect of pyridostigmine on the hydrocortisone-mediated decrease of circulating growth hormone levels in acromegaly.
Giustina A; Bussi AR; Doga M; Iacobello C; Wehrenberg WB
Horm Metab Res; 1994 Jun; 26(6):288-92. PubMed ID: 7927192
[TBL] [Abstract][Full Text] [Related]
7. Osteocalcin in normal adult humans of different sex and age.
Galli M; Caniggia M
Horm Metab Res; 1985 Mar; 17(3):165-6. PubMed ID: 3873386
[No Abstract] [Full Text] [Related]
8. Therapeutic efficacy of a somatostatin analogue (SMS 201-995) in active acromegaly.
Tolis G; Yotis A; del Pozo E; Pitoulis S
J Neurosurg; 1986 Jul; 65(1):37-40. PubMed ID: 2872284
[TBL] [Abstract][Full Text] [Related]
9. [Dose-dependent reduction of serum osteocalcin by corticoids].
Rico H; Cabranes JA; Yagüe M; Hernández ER; Escudero G
Med Clin (Barc); 1988 Jan; 90(1):14-6. PubMed ID: 3258052
[No Abstract] [Full Text] [Related]
10. Osteocalcin levels in Cushing's disease before and after treatment.
Sartorio A; Ambrosi B; Colombo P; Morabito F; Faglia G
Horm Metab Res; 1988 Jan; 20(1):70. PubMed ID: 3259531
[No Abstract] [Full Text] [Related]
11. [Osteocalcin and other biological parameters of phosphocalcium metabolism in Basedow's disease].
Fouquet B; Jollivet B; Valat C; Lecomte P; Besnard JC; Valat JP
Rev Rhum Mal Osteoartic; 1989 May; 56(6):459-62. PubMed ID: 2787047
[No Abstract] [Full Text] [Related]
12. [The study of parathyroid hormone and osteocalcin in patients with rheumatoid arthritis].
Ueyoshi A; Kiura Y; Ota K; Okamoto Y; Shimizu E
Ryumachi; 1987 Aug; 27(4):277-81. PubMed ID: 3502377
[No Abstract] [Full Text] [Related]
13. [Changes in serum osteocalcin after orthopedic surgery procedures].
Borsalino G; Borzoni R; Caravaggio F; Rocchi R; Pedrazzoni M; Palummeri E; Pioli G; Passeri M
G Clin Med; 1985; 66(11-12):393-400. PubMed ID: 3879688
[No Abstract] [Full Text] [Related]
14. [Basal serum osteocalcin in diseases associated with changes in bone metabolism].
León M; Larrodera L; Solís JA; Hawkins F
Med Clin (Barc); 1987 Jan; 88(3):90-2. PubMed ID: 3493401
[No Abstract] [Full Text] [Related]
15. Changes in serum osteocalcin following treatment of mild hyperthyroidism.
Naafs MA; de Boer AC; Fischer HR; Hackeng WH; Silberbusch J
Neth J Med; 1987 Aug; 31(1-2):52-7. PubMed ID: 2443862
[No Abstract] [Full Text] [Related]
16. One-year follow-up of patients with acromegaly treated with fixed or titrated doses of lanreotide Autogel.
Caron P; Bex M; Cullen DR; Feldt-Rasmussen U; Pico Alfonso AM; Pynka S; Racz K; Schopohl J; Tabarin A; Valimaki MJ;
Clin Endocrinol (Oxf); 2004 Jun; 60(6):734-40. PubMed ID: 15163338
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic-pharmacodynamic comparison of a novel multiligand somatostatin analog, SOM230, with octreotide in patients with acromegaly.
Ma P; Wang Y; van der Hoek J; Nedelman J; Schran H; Tran LL; Lamberts SW
Clin Pharmacol Ther; 2005 Jul; 78(1):69-80. PubMed ID: 16003295
[TBL] [Abstract][Full Text] [Related]
18. Effect of a long-term treatment with the aminosuberic analog of eel calcitonin on osteocalcin in Paget's disease.
Caniggia A; Nuti R; Galli M; Turchetti V; Righi G
Panminerva Med; 1987; 29(1):1-5. PubMed ID: 3496574
[No Abstract] [Full Text] [Related]
19. [Values of osteocalcin in diabetes mellitus and their variations according to treatment].
Rico H; Cabranes JA; Hernández ER; Almoguera I
Med Clin (Barc); 1987 May; 88(20):798-800. PubMed ID: 3298878
[No Abstract] [Full Text] [Related]
20. Serum osteocalcin levels in normal humans of different sex and age. An epidemiological study.
Cantatore FP; Carrozzo M; Magli D; D'Amore M; Pipitone V
Panminerva Med; 1988; 30(1):23-5. PubMed ID: 3262212
[No Abstract] [Full Text] [Related]
[Next] [New Search]
